HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bessell-Browne, R. Articles by O'Malley, M. E. Search for Related Content PubMed PubMed Citation Articles by Bessell-Browne, R. Articles by O'Malley, M. E. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

CT of Pheochromocytoma and Paraganglioma: Risk of Adverse Events with IV Administration of Nonionic Contrast Material

¹ Division of Abdominal Imaging, Department of Medical Imaging, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
² Department of Medical Imaging, Princess Margaret Hospital 3-956, 610 University Ave., Toronto, ON, Canada, M5G 2M9.

OBJECTIVE. When pheochromocytoma or paraganglioma is suspected, many institutions perform only unenhanced CT because of a perceived risk of inducing a hypertensive crisis with IV administration of contrast material. The purpose of this study was to review our experience with the use of nonionic IV contrast material for CT of patients with pheochromocytoma or paraganglioma. The specific goal was to determine whether adverse events occurred.

MATERIALS AND METHODS. A retrospective review of radiology records identified 25 patients (17 women, eight men; mean age, 43 years; age range, 27-70 years) with 40 pathologically proven pheochromocytomas or paragangliomas who received nonionic IV contrast material for CT. There were 16 adrenal pheochromocytomas, 12 abdominal paragangliomas, five neck paragangliomas, and seven metastatic lesions. Medical records were reviewed to determine whether the tumors were sporadic or associated with a syndrome, incidentally detected, or biochemically active; and whether patients were taking -blocking medication at the time of CT. Adverse events were documented.

RESULTS. Nineteen patients had 23 sporadic tumors, and six patients had 17 tumors associated with a syndrome. In 12 (48%) of the 25 patients the diagnosis was clinically unsuspected at the time of CT. Elevated levels of urinary catecholamines or their metabolites were found in 19 (90%) of the 21 patients for whom this test was performed. No patients were taking -blocking medication at the time of CT. No adverse events occurred in association with IV administration of nonionic contrast material.

CONCLUSION. IV administration of nonionic contrast material for CT is a safe practice for patients with pheochromocytoma and related tumors even without -blocking medication.

Keywords: abdominal imaging • adrenal gland • contrast media • CT • paraganglioma • pheochromocytoma • safety

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Sanyal and E. M. Remer Radiology of the Retroperitoneum: Self-Assessment Module Am. J. Roentgenol., June 1, 2009; 192(6_Supplement): S118 - S121. [Abstract] [Full Text] [PDF]

				G. W. L. Boland, M. A. Blake, P. F. Hahn, and W. W. Mayo-Smith Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization Radiology, December 1, 2008; 249(3): 756 - 775. [Abstract] [Full Text] [PDF]

				K. Rozovsky, B. Z. Koplewitz, Y. Krausz, S. Revel-Vilk, M. Weintraub, R. Chisin, and M. Klein Added Value of SPECT/CT for Correlation of MIBG Scintigraphy and Diagnostic CT in Neuroblastoma and Pheochromocytoma Am. J. Roentgenol., April 1, 2008; 190(4): 1085 - 1090. [Abstract] [Full Text] [PDF]

				A. L Rosas, A. A Kasperlik-Zaluska, L. Papierska, B. L. Bass, K. Pacak, and G. Eisenhofer Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature Eur. J. Endocrinol., March 1, 2008; 158(3): 423 - 429. [Abstract] [Full Text] [PDF]

				K. Pacak Preoperative Management of the Pheochromocytoma Patient J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4069 - 4079. [Abstract] [Full Text] [PDF]